Shares of Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) shot up 5.3% on Friday . The company traded as high as $0.82 and last traded at $0.80. 57,558 shares were traded during trading, a decline of 73% from the average session volume of 209,931 shares. The stock had previously closed at $0.76.
Separately, Ventum Cap Mkts raised shares of Ascend Wellness to a "strong-buy" rating in a research note on Tuesday, July 16th.
Get Our Latest Report on Ascend Wellness
The firm has a market capitalization of $170.16 million, a P/E ratio of -3.48 and a beta of 1.70. The company's 50 day moving average is $0.94 and its 200-day moving average is $1.03. The company has a quick ratio of 1.29, a current ratio of 2.29 and a debt-to-equity ratio of 2.46.
Ascend Wellness (OTC:AAWH - Get Free Report) last issued its earnings results on Monday, August 5th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.03). The company had revenue of $141.54 million for the quarter, compared to the consensus estimate of $145.48 million. Ascend Wellness had a negative return on equity of 50.77% and a negative net margin of 12.48%. As a group, equities analysts anticipate that Ascend Wellness Holdings, Inc. will post -0.32 EPS for the current year.
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.